1. Using Precision Medicine for the Diagnosis and Treatment of Viral Pneumonia

   • Richard R. Watkins

   Review Open access 21 May 2022 Pages: 3061 - 3071

   

2. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review

   • Cynthia Girman
   • Mary P. Panaccio
   • George J. Wan

   Review Open access 30 May 2022 Pages: 3072 - 3087

3. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus

   • Anca D. Askanase
   • Richard A. Furie

   Review Open access 31 May 2022 Pages: 3088 - 3103

   

4. The Impact of a Prenatal Education Program for Opioid-Dependent Mothers on Breastfeeding Rates of Infants at Risk for Neonatal Abstinence Syndrome

   • Brian Brocato
   • David Lewis
   • Richard M. Whitehurst Jr.

   Original Research 06 May 2022 Pages: 3104 - 3111

5. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea

   • Myung-Yong Lee
   • Sola Han
   • Young-Hoon Kim

   Original Research 07 May 2022 Pages: 3112 - 3130

   

6. Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study

   • Natalia Bello
   • Julie A. Birt
   • Michelle Petri

   Original Research Open access 09 May 2022 Pages: 3131 - 3145

   

7. Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study

   • Markus Cornberg
   • Adriana Ahumada
   • The CREST Study Group

   Original Research Open access 11 May 2022 Pages: 3146 - 3158

   

8. Matching-Adjusted Indirect Comparison (MAIC) of Tepotinib with Other MET Inhibitors for the Treatment of Advanced NSCLC with MET Exon 14 Skipping Mutations

   • Paul K. Paik
   • Boris M. Pfeiffer
   • Maarten J. Postma

   Original Research Open access 11 May 2022 Pages: 3159 - 3179

   

9. The Cost-Effectiveness of Oral Semaglutide in Spain: A Long-Term Health Economic Analysis Based on the PIONEER Clinical Trials

   • Josep Franch-Nadal
   • Samuel J. P. Malkin
   • Josep Vidal

   Original Research 12 May 2022 Pages: 3180 - 3198

   

10. Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis: Findings from Qualitative Research Using Patient Interviews

    • Mark Gudesblatt
    • Cortnee Roman
    • Shivani Kapadia

    Original Research Open access 13 May 2022 Pages: 3199 - 3213

    

11. Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan^® Databases

    • Craig Leonardi
    • Baojin Zhu
    • Andrew Blauvelt

    Original Research Open access 16 May 2022 Pages: 3214 - 3224

    

12. A Computational Platform Integrating a Mechanistic Model of Crohn’s Disease for Predicting Temporal Progression of Mucosal Damage and Healing

    • Sai Phanindra Venkatapurapu
    • Ryuichi Iwakiri
    • Jovelle Fernandez

    Original Research Open access 17 May 2022 Pages: 3225 - 3247

    

13. Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD

    • Angelo Maria Minnella
    • Chiara Centini
    • Martina Maceroni

    Original Research Open access 21 May 2022 Pages: 3248 - 3261

    

14. Cost-Effectiveness Analysis of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease in Canada

    • Jean Grégoire
    • Salimah Champsi
    • Raina M. Rogoza

    Original Research Open access 23 May 2022 Pages: 3262 - 3279

    

15. A Decreased Absolute Number of T_reg Cells in Patients with Active Rheumatoid Arthritis is Associated with Elevated Serum Osteopontin Levels with Disease Progression

    • Jian-Fang Xie
    • Jia Wang
    • Xiao-Feng Li

    Original Research 23 May 2022 Pages: 3280 - 3291

    

16. Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status

    • Qing Huang
    • Kathleen L. Deering
    • Lori A. Leslie

    Original Research Open access 24 May 2022 Pages: 3292 - 3307

    

17. Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study

    • Antimo Moretti
    • Sara Liguori
    • Giovanni Iolascon

    Original Research Open access 25 May 2022 Pages: 3308 - 3315

    

18. XaMINA: A Real-World, Prospective, Observational Study of Treatment-Naïve Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation in Asia

    • Ping-Yen Liu
    • Eue-Keun Choi
    • The XaMINA Investigators

    Original Research 26 May 2022 Pages: 3316 - 3333

    

19. Cost-Effectiveness of Donafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma in China

    • Haijing Guan
    • Chunping Wang
    • Sheng Han

    Original Research 29 May 2022 Pages: 3334 - 3346

    

20. Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations

    • Jinghua He
    • Christopher D. Pericone
    • Julie Vanderpoel

    Original Research 08 June 2022 Pages: 3347 - 3360

    

21. Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example

    • Eliza Kruger
    • Paul McNiven
    • Deborah Marsden

    Original Research Open access 08 June 2022 Pages: 3361 - 3377

    

22. Treatment Goals for Achondroplasia: A Qualitative Study with Parents and Adults

    • Sarah A. McGraw
    • Jeff C. Henne
    • Er Chen

    Original Research Open access 08 June 2022 Pages: 3378 - 3391

23. Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases

    • Francesco Bonella
    • Vincent Cottin
    • Toby M. Maher

    Brief Report Open access 14 May 2022 Pages: 3392 - 3402

    

24. MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory Diseases

    • Wayne J. G. Hellstrom
    • Radboud J. E. M. Dolhain
    • Walter Reinisch

    Study Protocol Open access 25 May 2022 Pages: 3403 - 3422

    

25. Correction to: Assessment of the Cost-Effectiveness of HER2-Targeted Treatment Pathways in the Neoadjuvant Treatment of High-Risk HER2-Positive Early-Stage Breast Cancer

    • Jesse A. Sussell
    • Joshua A. Roth
    • Svenn A. Hansen

    Correction 07 May 2022 Pages: 3423 - 3423

26. Correction to: Effects of High-Intensity Interval Training on Pulmonary Function and Exercise Capacity in Individuals with Chronic Obstructive Pulmonary Disease: A Meta-Analysis and Systematic Review

    • Min Gao
    • Yangxi Huang
    • Guozhen Sun

    Correction 13 May 2022 Pages: 3424 - 3424